AtriCure (ATRC) Tops Q3 EPS by 2c, provides guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $31.79 +6.93%
Revenue Growth %: +11.6%
Financial Fact:
Net loss: -6.78M
Today's EPS Names:
CRMT, More
Revenue Growth %: +11.6%
Financial Fact:
Net loss: -6.78M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $115.9 million versus the consensus estimate of $112.23 million.
FY 2024 Guidance:
EPS: ($0.74) - ($0.80), versus the guidance of ($0.77)
Revenue: $459 - $462 million, versus the guidance of $458.1 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight
- JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
